Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $20.38 million. The enterprise value is $17.62 million.
| Market Cap | 20.38M |
| Enterprise Value | 17.62M |
Important Dates
The next estimated earnings date is Sunday, August 3, 2025, before market open.
| Earnings Date | Aug 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 21.64 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 21.64M |
| Shares Outstanding | 21.64M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +2.40% |
| Owned by Insiders (%) | 82.12% |
| Owned by Institutions (%) | 0.05% |
| Float | 3.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.02 |
| P/TBV Ratio | 5.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.88 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -60.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$84,169 |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 32.51 |
| Average Volume (20 Days) | 36,320 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.51M |
| Pretax Income | -4.75M |
| Net Income | -3.37M |
| EBITDA | -2.21M |
| EBIT | -2.51M |
| Earnings Per Share (EPS) | -$0.17 |
Balance Sheet
The company has $5.18 million in cash and $2.07 million in debt, giving a net cash position of $3.12 million or $0.14 per share.
| Cash & Cash Equivalents | 5.18M |
| Total Debt | 2.07M |
| Net Cash | 3.12M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 4.13M |
| Book Value Per Share | 0.19 |
| Working Capital | 3.62M |
Cash Flow
In the last 12 months, operating cash flow was -$4.76 million and capital expenditures -$64,757, giving a free cash flow of -$4.82 million.
| Operating Cash Flow | -4.76M |
| Capital Expenditures | -64,757 |
| Free Cash Flow | -4.82M |
| FCF Per Share | -$0.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Advanced Biomed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | -16.24% |
| FCF Yield | -23.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |